Lv3
214 积分 2024-05-21 加入
Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study
3天前
已完结
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
3天前
已完结
Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
4天前
已完结
Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag
4天前
已完结
Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data
4天前
已完结
Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN‐France Registry
4天前
已完结
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia
4天前
已完结
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
4天前
已完结
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial
6天前
已完结
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
7天前
已完结
地方政府债券市场化定价研究
5天前
已采纳
基于注意力的多层次混合融合的多任务多模态情感分析
5天前
已采纳
急性胰腺炎胰腺外分泌功能不全及胰酶替代治疗
20天前
已采纳
心率变异性临床研究现状及应用进展
20天前
已采纳
多囊性肝病的诊断治疗进展
21天前
已采纳
皖公网安备34019202002308
